AKTX Akari Therapeutics Plc gains 27% Mar 14, 2019
As of September 18, 2015, Celsus Therapeutics Plc was acquired by Akari Therapeutics, Plc, in a reverse merger transaction. Celsus Therapeutics Plc, a development stage biopharmaceutical company, engages in the discovery and development of non-ste...http://www.priceseries.com/trade/AKTX-Akari-Therapeutics-Plc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2019031320190314.html